Cost of illness of tuberculosis in Penang, Malaysia
Cost of illness of tuberculosis in Penang, Malaysia
复制标题
DOI：
10.1007/s11096-007-9185-0
复制
发表时间：
2008-06-01
影响因子：
--
通讯作者：
Muttalif, Abdul Razak
中科院分区：
文献类型：
--
作者：
Elamin, Elfatih Ibrahim;Ibrahim, Mohamed Izham Mohamed;Muttalif, Abdul Razak
目的 评估公共卫生服务和患者因结核病 (TB) 治疗而产生的费用。背景 这项研究是在马来西亚北部地区的一家政府医院进行的。方法回顾性收集病历资料，观察患者直至用药完成。应用药物经济学评估来计算直接和间接成本。主要成果衡量政府卫生机构结核病治疗的直接和间接费用。结果 201 名结核病患者纳入研究。使用具有不同治疗持续时间的不同方案。计算直接医疗和非医疗费用以及间接费用如下：抗结核药物和用品 61.44 美元、X 光检查 28.63 美元、实验室检查 28.53 美元、医护人员时间 20.03 美元、住院费用 4.28 美元、间接费用 43.20 美元、交通和医疗费用 608.11 美元。 餐费和下班时间 118.78 美元。患者的费用约占治疗总费用的80%。结论 每名患者治疗结核病的费用为 916.4 美元。抗结核药物的费用在公共卫生服务费用中所占比例最高（31.7%），而患者的费用则在疾病总费用中所占比例最大（79.4%）。
Objective To assess the costs incurred by the public health services and patients as a result of tuberculosis (TB) treatment. Setting The study was conducted in a government hospital located in the northern region of Malaysia. Method Retrospective data were collected from medical records and the patients were observed until the completion of their medication. A pharmacoeconomic evaluation was applied to calculate direct and indirect costs. Main Outcome Measure Direct and indirect costs of tuberculosis treatment in a government health institution. Results Two hundred and one tuberculosis patients were included in the study. Different regimens with various durations of treatments were used. The direct medical and non-medical costs as well as indirect costs were calculated and were found to be as follows: US$61.44 for anti-tuberculosis drugs and supplies, US$28.63 for X-ray examinations, US$28.53 for laboratory tests, US$20.03 for healthcare staff time, US$4.28 for hospitalisation, US$43.20 for overhead costs, US$608.11 for transportation and meals and US$118.78 for time away from work. The cost to the patients constitutes approximately 80% of the total cost of the treatment. Conclusion The cost of treating the illness of tuberculosis per patient was US$916.4. The cost of anti-tuberculosis drugs constituted the highest proportion of the cost to the public health services (31.7%) while the cost to the patient constituted the major proportion of the total cost of the illness (79.4%).